Vaporized liquid nitrogen is currently the only workable means of maintaining the ultra-cold temperatures necessary for certain therapeutics and tissue samples.

Enrolling patients in clinical trials has become an increasingly challenging task.

According to key opinion leaders in biopharma cold chain, the biopharma industry is increasing its pace to prioritize sustainability in business and operational strategies. Nearly half of all respondents already always factor sustainability into cold chain purchasing decisions.

A report looking into differing types of temperature controlled packaging (single use, reusable, passive, active) and its impact on the environment

As strong growth continues across the global pharmaceuticals industry, the sub-category of temperature-controlled products is surging ahead.

A report looking at the ways in which pharmaceutical products are shipped worldwide is changing as new technologies allow customers to trace, trace and pack more effectively

It is the goal of this research to identify current packaging options that limit this environmental impact.

Active or Passive? - this White Paper gives guidance on making the optimum choice when bulk shipping temperature sensitive pharmaceutical products.

The challenge of controlled room temperature shipments includes limitations of water-based coolant systems, profile manipulation, and conditioning process control.